ShareValue.ai

ShareValue scores for 301201.SHE: Valuation 36, Quality 36, Growth 62, Health 53.

301201.SHE
SZSE

ChengDa Pharmaceuticals Co. Ltd.

CN¥33.29(-12.85%)
Loading chart...
Sentiment

Verdicts

Rating

Trap Risk

Return

-6% to 11%
Valuation
36
Overvalued
Price vs Value
Quality
36
Weak
Business Strength
Growth
62
Moderate
Revenue & Earnings
Health
53
Moderate
Financial Stability
Momentum
62
Bullish
Price Trend

Company Details

About

ChengDa Pharmaceuticals Co., Ltd. engages in the research and development, production, and sale of pharmaceutical intermediates, chemical ingredients, and food and feed additives in China and internationally. It offers process research and development, process optimization, quality and stability research, customized production and other services for pharmaceutical intermediates and APIs; and food and feed additives, such as L-carnitine and L-carnitine tartrate. The company also provides bulk drug products, including urogenital, nervous system, blood and hematopoietic organs, muscular system, digestive tract and metabolism, antineoplastic and immunomodulators; and pharmaceutical intermediates comprising drug intermediates for blood and hematopoietic organs, drug intermediates in digestive tract and metabolism, and nervous system drug intermediates. ChengDa Pharmaceuticals Co., Ltd. was founded in 1980 and is based in Jiaxing, China.

Score Analysis

AI Investment Thesis

Data as of:Jul 17, 2026
|
Last calculated:Jul 17, 2026